Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Br J Radiol

Retrieve available abstracts of 43 articles:
HTML format



Single Articles


    October 2021
  1. DEL MONTE M, Cipollari S, Del Giudice F, Pecoraro M, et al
    MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques.
    Br J Radiol. 2021 Oct 5:20210528. doi: 10.1259/bjr.20210528.
    PubMed     Abstract available


    September 2021
  2. WU YY, Fan KH
    Proton therapy for prostate cancer: current state and future perspectives.
    Br J Radiol. 2021 Sep 24:20210670. doi: 10.1259/bjr.20210670.
    PubMed     Abstract available


  3. TAMADA T, Kido A, Ueda Y, Takeuchi M, et al
    Clinical impact of ultra-high b-value (3000 s/mm(2)) diffusion-weighted magnetic resonance imaging in prostate cancer at 3T: comparison with b-value of 2000 s/mm(2).
    Br J Radiol. 2021 Sep 24:20210465. doi: 10.1259/bjr.20210465.
    PubMed     Abstract available


  4. UENO Y, Tamada T, Sofue K, Murakami T, et al
    Diffusion and quantification of diffusion of prostate cancer.
    Br J Radiol. 2021 Sep 19:20210653. doi: 10.1259/bjr.20210653.
    PubMed     Abstract available


  5. SUSHENTSEV N, Caglic I, Rundo L, Kozlov V, et al
    Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression.
    Br J Radiol. 2021 Sep 19:20210842. doi: 10.1259/bjr.20210842.
    PubMed     Abstract available


  6. ZAPATERO A, Roch M, Castro Tejero P, Buchser D, et al
    MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial.
    Br J Radiol. 2021 Sep 19:20210683. doi: 10.1259/bjr.20210683.
    PubMed     Abstract available


    August 2021
  7. LEE YS, Choi MH, Lee YJ, Han D, et al
    Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
    Br J Radiol. 2021 Aug 20:20210479. doi: 10.1259/bjr.20210479.
    PubMed     Abstract available


  8. IPPOLITI S, Fletcher P, Orecchia L, Miano R, et al
    Optimal biopsy approach for detection of clinically significant prostate cancer.
    Br J Radiol. 2021 Aug 6:20210413. doi: 10.1259/bjr.20210413.
    PubMed     Abstract available


  9. CHAPET O, Udrescu C, Bin S, Decullier E, et al
    Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.
    Br J Radiol. 2021;94:20210242.
    PubMed     Abstract available


    July 2021
  10. PAXTON M, Barbalat E, Perlis N, Menezes RJ, et al
    Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer.
    Br J Radiol. 2021 Jul 29:20210414. doi: 10.1259/bjr.20210414.
    PubMed     Abstract available


  11. ZHANG L, Jiang D, Chen C, Yang X, et al
    Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
    Br J Radiol. 2021 Jul 21:20210191. doi: 10.1259/bjr.20210191.
    PubMed     Abstract available


  12. BENHMIDA S, Beneux A, Udrescu C, Rouviere O, et al
    Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing.
    Br J Radiol. 2021 Jul 20:20210142. doi: 10.1259/bjr.20210142.
    PubMed     Abstract available


  13. MAZZOLA R, Sicignano G, Cuccia F, Vitale C, et al
    Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
    Br J Radiol. 2021 Jul 20:20210521. doi: 10.1259/bjr.20210521.
    PubMed     Abstract available


  14. KIM Y, Park JJ, Kim CK
    Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience.
    Br J Radiol. 2021 Jul 8:20210461. doi: 10.1259/bjr.20210461.
    PubMed     Abstract available


  15. GIGANTI F, Allen C, Stavrinides V, Stabile A, et al
    Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
    Br J Radiol. 2021 Jul 8:20210321. doi: 10.1259/bjr.20210321.
    PubMed     Abstract available


    June 2021
  16. KUMASAKA S, Motegi S, Kumasaka Y, Nishikata T, et al
    Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
    Br J Radiol. 2021 Jun 11:20210459. doi: 10.1259/bjr.20210459.
    PubMed     Abstract available


  17. QUINTERO P, Cheng Y, Benoit D, Moore C, et al
    Effect of treatment planning system parameters on beam modulation complexity for treatment plans with single-layer multi-leaf collimator and dual-layer stacked multi-leaf collimator.
    Br J Radiol. 2021;94:20201011.
    PubMed     Abstract available


    April 2021
  18. BROOKS RL, McCallum HM, Pearson RA, Pilling K, et al
    Are cone beam CT image matching skills transferrable from planning CT to planning MRI for MR-only prostate radiotherapy?
    Br J Radiol. 2021 Apr 29:20210146. doi: 10.1259/bjr.20210146.
    PubMed     Abstract available


  19. URASE Y, Ueno Y, Tamada T, Sofue K, et al
    Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer.
    Br J Radiol. 2021 Apr 21:20201434. doi: 10.1259/bjr.20201434.
    PubMed     Abstract available


  20. KUO YH, Liang JA, Chen GH, Li CC, et al
    Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.
    Br J Radiol. 2021 Apr 16:20200456. doi: 10.1259/bjr.20200456.
    PubMed     Abstract available


  21. BEDFORD JL, Hanson IM
    Optimisation of a composite difference metric for prompt error detection in real-time portal dosimetry of simulated volumetric modulated arc therapy.
    Br J Radiol. 2021;94:20201014.
    PubMed     Abstract available


  22. YANG FJ, Ai SY, Wu R, Lv Y, et al
    Impact of total variation regularized expectation maximization reconstruction on the image quality of (68)Ga-PSMA PET: a phantom and patient study.
    Br J Radiol. 2021;94:20201356.
    PubMed     Abstract available


    March 2021
  23. HE X, Xiong H, Zhang H, Liu X, et al
    Value of MRI texture analysis for predicting new Gleason grade group.
    Br J Radiol. 2021 Mar 11:20210005. doi: 10.1259/bjr.20210005.
    PubMed     Abstract available


  24. HWANG ME, Mayeda M, Shaish H, Elliston CD, et al
    Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Br J Radiol. 2021;94:20200433.
    PubMed     Abstract available


    February 2021
  25. KOWA JY, Soneji N, Sohaib SA, Mayer E, et al
    Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
    Br J Radiol. 2021 Feb 15:20201423. doi: 10.1259/bjr.20201423.
    PubMed     Abstract available


    January 2021
  26. HEARN N, Blazak J, Vivian P, Vignarajah D, et al
    Prostate cancer GTV delineation with biparametric MRI and (68)Ga-PSMA-PET: comparison of expert contours and semi-automated methods.
    Br J Radiol. 2021 Jan 28:20201174. doi: 10.1259/bjr.20201174.
    PubMed     Abstract available


    October 2020
  27. UGURLUER G, Atalar B, Zoto Mustafayev T, Gungor G, et al
    Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results.
    Br J Radiol. 2020 Oct 23:20200696. doi: 10.1259/bjr.20200696.
    PubMed     Abstract available


  28. ALONGI F, Rigo M, Figlia V, Cuccia F, et al
    Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
    Br J Radiol. 2020 Oct 23:20200848. doi: 10.1259/bjr.20200848.
    PubMed     Abstract available


  29. WADERA A, Alabousi M, Pozdnyakov A, Kashif Al-Ghita M, et al
    Impact of PI-RADS 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and Meta-Analysis.
    Br J Radiol. 2020 Oct 1:20191050. doi: 10.1259/bjr.20191050.
    PubMed     Abstract available


  30. CHETIYAWARDANA G, Hoskin PJ, Tsang YM
    The implementation of an empty bladder filling protocol for localised prostate volumetric modulated arctherapy (VMAT): early results of a single institution service evaluation.
    Br J Radiol. 2020;93:20200548.
    PubMed     Abstract available


  31. GIGANTI F, Allen C
    Imaging quality and prostate MR: it's time to improve.
    Br J Radiol. 2020 Oct 1:20200934. doi: 10.1259/bjr.20200934.
    PubMed     Abstract available


    September 2020
  32. GIGANTI F, Stavrinides V, Stabile A, Osinibi E, et al
    Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISE.
    Br J Radiol. 2020 Sep 21:20200819. doi: 10.1259/bjr.20200819.
    PubMed     Abstract available


  33. ALSHEHRI AHD, Osman SOS, Prise KM, Campfield C, et al
    A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer.
    Br J Radiol. 2020 Sep 3:20200775. doi: 10.1259/bjr.20200775.
    PubMed     Abstract available


    August 2020
  34. PILIERO MA, Casiraghi M, Bosetti DG, Cima S, et al
    Patient-based low dose cone beam CT acquisition settings for prostate image-guided radiotherapy treatments on a Varian TrueBeam linear accelerator.
    Br J Radiol. 2020 Aug 27:20200412. doi: 10.1259/bjr.20200412.
    PubMed     Abstract available


  35. KAO J, Karwowski P, Pettit J, Barney AK, et al
    Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications.
    Br J Radiol. 2020 Aug 26:20200571. doi: 10.1259/bjr.20200571.
    PubMed     Abstract available


  36. YAN M, Moideen N, Bratti VF, Moraes FY, et al
    Stereotactic body radiotherapy (SBRT) in metachronousoligometastatic prostate cancer: a systematic review and meta-analysis on the current prospective evidence.
    Br J Radiol. 2020 Aug 21:20200496. doi: 10.1259/bjr.20200496.
    PubMed     Abstract available


  37. SCHUMACHER LD, Dal Pra A, Hoffe SE, Mellon EA, et al
    Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.
    Br J Radiol. 2020 Aug 12:20200028. doi: 10.1259/bjr.20200028.
    PubMed     Abstract available


  38. YOUNG S, Gasparetto A, Jalaeian H, Golzarian J, et al
    Biomarkers in the setting of benign prostatic hyperplasia-induced lower urinary tract symptoms: what an interventional radiologist needs to know.
    Br J Radiol. 2020 Aug 6:20200484. doi: 10.1259/bjr.20200484.
    PubMed     Abstract available


  39. SINGH G, Kamal R, Thaper D, Oinam AS, et al
    Voxel based evaluation of sequential radiotherapy treatment plans with different dose fractionation schemes.
    Br J Radiol. 2020;93:20200197.
    PubMed     Abstract available


    July 2020
  40. TAYLOR T, Richmond N
    A UK wide study of current prostate planning practice.
    Br J Radiol. 2020;93:20200142.
    PubMed     Abstract available


    June 2020
  41. ASHTON J, Bristow R
    Bad neighbours: hypoxia and genomic instability in prostate cancer.
    Br J Radiol. 2020 Jun 18:20200087. doi: 10.1259/bjr.20200087.
    PubMed     Abstract available


  42. ZAWAIDEH JP, Sala E, Pantelidou M, Shaida N, et al
    Comparison of likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer.
    Br J Radiol. 2020 Jun 1:20200298. doi: 10.1259/bjr.20200298.
    PubMed     Abstract available


    March 2020
  43. EMARA DM, Naguib NN, Yehia M, El Shafei MM, et al
    Ultrasound elastography in characterization of prostatic lesions: correlation with histopathological findings.
    Br J Radiol. 2020 Mar 6:20200035. doi: 10.1259/bjr.20200035.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: